Sanofi (SNY) Prepaid Assets (2009 - 2026)
Sanofi (SNY) posted Prepaid Assets of $5.0 billion for Q2 2026, down 94.19% sequentially from $85.6 billion in Q1 2026, and up 22.31% YoY from $4.1 billion in Q2 2025.
Sanofi (SNY) Prepaid Assets (2009 - 2026) Analysis & Trends
Sanofi has reported Prepaid Assets for 18 years, with the latest figure at $5.0 billion in Q2 2026.
- Quarterly Prepaid Assets rose 22.31% year-over-year to $5.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.0 billion (up 22.31% YoY) and the FY2025 annual result came in at $4.7 billion, up 15.77% from the prior year.
- Prepaid Assets fell to $5.0 billion in Q2 2026 per SNY's latest filing, from $85.6 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $86.0 billion in Q3 2025 and troughed at $159.2 million in Q4 2022.
- A 5-year average of $23.6 billion and a median of $4.1 billion in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets plunged 96.1% in 2022, then surged 2235.64% in 2023.
- Over 5 years, Prepaid Assets stood at $159.2 million in 2022, then soared by 2235.64% to $3.7 billion in 2023, then rose by 9.98% to $4.1 billion in 2024, then grew by 15.77% to $4.7 billion in 2025, then climbed by 5.16% to $5.0 billion in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.0 billion, $85.6 billion, and $4.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.98 Bn |
| Mar 31, 2026 | 85.63 Bn |
| Dec 31, 2025 | 4.73 Bn |
| Sep 30, 2025 | 85.96 Bn |
| Jun 30, 2025 | 4.07 Bn |
| Mar 31, 2025 | 78.28 Bn |
| Dec 31, 2024 | 4.09 Bn |
| Jun 30, 2024 | 4.17 Bn |
| Dec 31, 2023 | 3.72 Bn |
| Jun 30, 2023 | 3.67 Bn |
| Dec 31, 2022 | 159.16 Mn |
| Jun 30, 2022 | 3.94 Bn |
| Dec 31, 2021 | 4.09 Bn |
| Jun 30, 2021 | 3.73 Bn |
| Dec 31, 2020 | 3.26 Bn |
| Jun 30, 2020 | 3.00 Bn |
| Dec 31, 2019 | 44.16 Mn |
| Jun 30, 2019 | 3.28 Bn |
| Dec 31, 2018 | 2.31 Bn |
| Sep 30, 2018 | 46.53 Mn |